UPDATE 2-FDA panel against higher dose of Lilly-Incyte arthritis drug By: Reuters: Company News April 23, 2018 at 18:44 PM EDT * Approval in only 2 mg dose limits commercial potential- analysts Read More >> Related Stocks: Eli Lilly Incyte Corp